C57BL/6JCya-Ccnl1em1flox/Cya
Common Name
Ccnl1-flox
Product ID
S-CKO-12200
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-56706-Ccnl1-B6J-VA
When using this mouse strain in a publication, please cite “Ccnl1-flox Mouse (Catalog S-CKO-12200) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Ccnl1-flox
Strain ID
CKOCMP-56706-Ccnl1-B6J-VA
Gene Name
Product ID
S-CKO-12200
Gene Alias
2610030E23Rik, Ccnl, ania-6a
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
Chr 3
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000029416
NCBI RefSeq
NM_019937
Target Region
Exon 4
Size of Effective Region
~0.6 kb
Overview of Gene Research
Ccnl1, also known as Cyclin L1, is a non-canonical cyclin. It is involved in multiple biological processes. Functionally, it participates in pre-mRNA splicing activities as it interacts with TFIP11 and EWSR1 which are related to the spliceosome [5]. It also plays a role in cell cycle regulation, specifically at the G2-M phase as part of the CCNL1-CDK11 complex [1].
In cancer-related research, loss-of-function experiments have shown significant results. In pancreatic cancer, knockout of Ccnl1 enhanced gemcitabine resistance by activating the ERK/AKT/STAT3 survival pathway [4]. In prostate cancer, miR-5195-3p, which targets Ccnl1, acts as a tumor suppressor, with overexpression of miR-5195-3p suppressing cell proliferation and cell cycle G1/S transition [2]. In osteosarcoma, Ccnl1 promotes cell proliferation, migration, and Adriamycin resistance through the PI3K/AKT-mTOR pathway [3].
In conclusion, Ccnl1 is crucial for pre-mRNA splicing and cell cycle regulation. Its role in cancer-related processes, such as drug resistance and tumor cell proliferation in pancreatic, prostate, and osteosarcoma cancers, has been revealed through loss-of-function studies. Understanding Ccnl1 can provide potential targets for cancer treatment.
References：
1. O'Brien, Siobhan, Kelso, Susan, Steinhart, Zachary, Sicheri, Frank, Angers, Stephane. 2022. SCFFBXW7 regulates G2-M progression through control of CCNL1 ubiquitination. In EMBO reports, 23, e55044. doi:10.15252/embr.202255044. https://pubmed.ncbi.nlm.nih.gov/36278408/
2. Zeng, Xing, Hu, Zhiquan, Shen, Yuanqing, Gan, Jiahua, Liu, Zheng. 2022. MiR-5195-3p functions as a tumor suppressor in prostate cancer via targeting CCNL1. In Cellular & molecular biology letters, 27, 25. doi:10.1186/s11658-022-00326-8. https://pubmed.ncbi.nlm.nih.gov/35260070/
3. Zhang, Yanbin, Zhang, Tao, Chen, Long, Guo, Zijun, Jiang, Xiaobing. 2024. Cyclin L1 participates in Adriamycin resistance and progression of osteosarcoma via PI3K/AKT-mTOR pathway. In Aging, 16, 11208-11223. doi:10.18632/aging.205972. https://pubmed.ncbi.nlm.nih.gov/39024509/
4. Yang, Hai, Liu, Bin, Liu, Dongxue, Grützmann, Robert, Pilarsky, Christian. 2022. Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer. In Cancers, 14, . doi:10.3390/cancers14133152. https://pubmed.ncbi.nlm.nih.gov/35804923/
5. Tannukit, Sissada, Wen, Xin, Wang, HongJun, Paine, Michael L. 2008. TFIP11, CCNL1 and EWSR1 Protein-protein Interactions, and Their Nuclear Localization. In International journal of molecular sciences, 9, 1504-1514. doi:10.3390/ijms9081504. https://pubmed.ncbi.nlm.nih.gov/19122807/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.